Inactive Instrument

Intercell AG Share Price

Equities

Duration

Period

Style

Intercell AG : Annual Report 2011	16/04/12	PU
Intercell AG : Intercell and Statens Serum Institut (SSI) progress vaccine clinical development to fight Tuberculosis	11/01/12	PU
Intercell AG : Thomas Szucs elected new chairman of Intercell’s Supervisory Board	30/12/11	PU
Intercell AG : Intercell and Biological E. Ltd. announce approval for Japanese Encephalitis vaccine in India	10/11/11	PU
Intercell AG : announces Q3 2011 results and provides an update on ongoing operations	08/11/11	PU

VIVALIS : et Intercell fusionnent pour former Valneva	17/12/12
Intercell AG : La biotech française Vivalis rachète l'autrichienne Intercell	17/12/12
Un vaccin expérimental contre l'hépatite C développé en France	04/08/11
INTERCELL ORD INTERCELL AG ORD SHS : Intercell : la dégringolade	24/05/11

Sector

	1st Jan change	Capi.
CSL LIMITED	-4.06%	86.13B
SAMSUNG BIOLOGICS CO.,LTD.	+1.97%	39.82B
UCB	+56.59%	25.23B
BIOMARIN PHARMACEUTICAL INC.	-13.72%	15.36B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-8.82%	11.95B
INCYTE CORPORATION	-15.74%	11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-41.58%	11.51B
SWEDISH ORPHAN BIOVITRUM AB	+6.14%	8.71B
INNOVENT BIOLOGICS, INC.	-7.02%	8.12B